This inventor holds 2 USPTO granted patents. Top assignee: Research, Incorporated. Active years: 1981-1982.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1981-1982
Title: Yalamanchili Gopichand: Innovator in Antitumor and Antibiotic Research
Introduction
Yalamanchili Gopichand is a notable inventor based in Norman, OK (US). He has made significant contributions to the field of biomedical research, particularly in the development of new antitumor and antibiotic agents. With a total of 2 patents to his name, Gopichand's work is recognized for its potential impact on healthcare.
Latest Patents
Gopichand's latest patents include innovative compounds that show promise in treating various medical conditions. One of his notable inventions is Acanthifolic acid, which is described as a new antitumor and antibiotic agent. This purified bioactive compound is characterized by a specific formula, wherein Q is selected from the group consisting of OY and NZ.sub.1 Z.sub.2. This compound has the potential to provide new therapeutic options for patients.
Career Highlights
Throughout his career, Gopichand has been associated with Research, Incorporated, where he has focused on advancing scientific knowledge and developing new medical treatments. His dedication to research and innovation has positioned him as a key figure in his field.
Collaborations
Gopichand has worked alongside esteemed colleagues, including Dick Van Der Helm and Ravi S Prasad. These collaborations have fostered a productive environment for research and development, leading to significant advancements in their respective areas of expertise.
Conclusion
Yalamanchili Gopichand's contributions to the field of biomedical research are noteworthy. His innovative work in developing new antitumor and antibiotic agents showcases his commitment to improving healthcare outcomes. With his ongoing research efforts, Gopichand continues to make a meaningful impact in the scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile